Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Rojo

Showing results (71-80 of 146) with videos related to

Pageof 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2017
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and FormulationsMartina Penazzato, Devasena Gnanashanmugam, Pablo Rojo, et al.
The Journal of Infection|December 19, 2017
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trialFederico Martinón-Torres, Alfonso Carmona Martinez, Róbert Simkó, et al.
Atherosclerosis|February 18, 2014
Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalitiesTalía Sainz, Laura Diaz, María Luisa Navarro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Functionally defective high-density lipoproteins are related to heightened T-cell activation in vertically HIV-infected adolescentsTalía Sainz, Adriana Ortega-Hernández, Sergio Serrano-Villar, et al.
Journal of the Pediatric Infectious Diseases Society|July 18, 2020
The CARMA Study: Early Infant Antiretroviral Therapy-Timing Impacts on Total HIV-1 DNA Quantitation 12 Years LaterCaroline Foster, Sara Domínguez-Rodríguez, Alfredo Tagarro, et al.
Plos One|August 6, 2019
Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected childrenSara Guillén, Luis Prieto, Santiago Jiménez de Ory, et al.
The Pediatric Infectious Disease Journal|December 23, 2016
Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and SenescenceBeatriz Jiménez, Talía Sainz, Laura Díaz, et al.
AIDS (London, England)|December 6, 2012
Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infantsElena Chiappini, Luisa Galli, Carlo Giaquinto, et al.
Journal of the International AIDS Society|November 19, 2021
Size of HIV-1 reservoir is associated with telomere shortening and immunosenescence in early-treated European children with perinatally acquired HIV-1Annalisa Dalzini, Giovanni Ballin, Sara Dominguez-Rodriguez, et al.
The Lancet. HIV|September 10, 2019
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 listMartina Penazzato, Claire L Townsend, Natella Rakhmanina, et al.
Pageof 15

Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2017
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and FormulationsMartina Penazzato, Devasena Gnanashanmugam, Pablo Rojo, et al.
The Journal of Infection|December 19, 2017
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trialFederico Martinón-Torres, Alfonso Carmona Martinez, Róbert Simkó, et al.
Atherosclerosis|February 18, 2014
Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalitiesTalía Sainz, Laura Diaz, María Luisa Navarro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Functionally defective high-density lipoproteins are related to heightened T-cell activation in vertically HIV-infected adolescentsTalía Sainz, Adriana Ortega-Hernández, Sergio Serrano-Villar, et al.
Journal of the Pediatric Infectious Diseases Society|July 18, 2020
The CARMA Study: Early Infant Antiretroviral Therapy-Timing Impacts on Total HIV-1 DNA Quantitation 12 Years LaterCaroline Foster, Sara Domínguez-Rodríguez, Alfredo Tagarro, et al.
Plos One|August 6, 2019
Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected childrenSara Guillén, Luis Prieto, Santiago Jiménez de Ory, et al.
The Pediatric Infectious Disease Journal|December 23, 2016
Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and SenescenceBeatriz Jiménez, Talía Sainz, Laura Díaz, et al.
AIDS (London, England)|December 6, 2012
Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infantsElena Chiappini, Luisa Galli, Carlo Giaquinto, et al.
Journal of the International AIDS Society|November 19, 2021
Size of HIV-1 reservoir is associated with telomere shortening and immunosenescence in early-treated European children with perinatally acquired HIV-1Annalisa Dalzini, Giovanni Ballin, Sara Dominguez-Rodriguez, et al.
The Lancet. HIV|September 10, 2019
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 listMartina Penazzato, Claire L Townsend, Natella Rakhmanina, et al.
Pageof 15